Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study

Robert Flisiak; Dorota Zarębska-Michaluk; Aleksandra Berkan-Kawińska; Magdalena Tudrujek-Zdunek; Magdalena Rogalska; Anna Piekarska; Dorota Kozielewicz; Krzysztof Kłos; Marta Rorat; Beata Bolewska; Anna Szymanek-Pasternak; Włodzimierz Mazur; Beata Lorenc; Regina Podlasin; Katarzyna Sikorska; Barbara Oczko-Grzesik; Cezary Iwaszkiewicz; Bartosz Szetela; Paweł Pabjan; Małgorzata Pawłowska; Krzysztof Tomasiewicz; Joanna Polańska; Jerzy Jaroszewicz

doi:10.20452/pamw.15735

Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study

Pol Arch Intern Med. 2021 Jan 29;131(1):103-110. doi: 10.20452/pamw.15735. Epub 2020 Dec 31.

Authors

Robert Flisiak^#¹, Dorota Zarębska-Michaluk^#², Aleksandra Berkan-Kawińska³, Magdalena Tudrujek-Zdunek⁴, Magdalena Rogalska⁵, Anna Piekarska³, Dorota Kozielewicz⁶, Krzysztof Kłos⁷, Marta Rorat^{8

9}, Beata Bolewska¹⁰, Anna Szymanek-Pasternak¹¹, Włodzimierz Mazur¹², Beata Lorenc¹³, Regina Podlasin¹⁴, Katarzyna Sikorska¹⁵, Barbara Oczko-Grzesik¹⁶, Cezary Iwaszkiewicz¹⁷, Bartosz Szetela¹⁸, Paweł Pabjan², Małgorzata Pawłowska⁵, Krzysztof Tomasiewicz⁴, Joanna Polańska¹⁹, Jerzy Jaroszewicz¹⁶

Affiliations

¹ Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Białystok, Poland. [email protected]
² Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
³ Department of Infectious Diseases and Hepatology, Medical University of Lodz, Łódź, Poland
⁴ Department of Infectious Diseases and Hepatology, Medical University of Lublin, Lublin, Poland
⁵ Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Białystok, Poland
⁶ Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland
⁷ Department of Infectious Diseases and Allergology, Military Institute of Medicine, Warsaw, Poland
⁸ Department of Forensic Medicine, Wroclaw Medical University, Wrocław, Poland
⁹ 1st Infectious Diseases Ward, Gromkowski Regional Specialist Hospital in Wrocław, Wrocław, Poland
¹⁰ Department of Infectious Diseases, Poznan University of Medical Sciences, Poznań, Poland
¹¹ Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Wrocław, Poland
¹² Clinical Department of Infectious Diseases in Chorzów, Medical University of Silesia, Katowice, Poland
¹³ Department of Infectious Diseases, Pomeranian Center of Infectious Diseases, Medical University of Gdańsk, Gdańsk, Poland
¹⁴ Hospital of Infectious Diseases in Warsaw, Warsaw, Poland
¹⁵ Department of Tropical Medicine and Epidemiology, Medical University of Gdańsk, Gdańsk, Poland
¹⁶ Department of Infectious Diseases in Bytom, Medical University of Silesia, Katowice, Poland
¹⁷ Department of Rheumatology and Osteoporosis, Józef Struś Hospital, Poznań, Poland
¹⁸ Department of Infectious Diseases, Liver Diseases and Acquired Immune Deficiencies, Wroclaw Medical University, Wrocław, Poland
¹⁹ Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland

^# Contributed equally.

PMID: 33382547
DOI: 10.20452/pamw.15735

No abstract available

Publication types

Multicenter Study

MeSH terms

Adenosine Monophosphate / analogs & derivatives*
Adenosine Monophosphate / therapeutic use
Adult
Aged
Alanine / analogs & derivatives*
Alanine / therapeutic use
Antiviral Agents / therapeutic use*
COVID-19 Drug Treatment*
Drug Combinations
Female
Humans
Lopinavir / therapeutic use*
Male
Middle Aged
Poland
Risk Factors
Ritonavir / therapeutic use*
Severity of Illness Index
Treatment Outcome

Substances

Antiviral Agents
Drug Combinations
lopinavir-ritonavir drug combination
Lopinavir
remdesivir
Adenosine Monophosphate
Ritonavir
Alanine